OHARA PHARMACEUTICAL
Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.
OHARA PHARMACEUTICAL
Industry:
Biotechnology Genetics Manufacturing Pharmaceutical
Founded:
1964-11-05
Status:
Active
Contact:
81-3-6740-7701
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
China Botanic Pharmaceutical
China Botanic Pharmaceutical is engaged in the research, development, manufacturing, and distribution of botanical products
Current Employees Featured
Seiji Ohara President and CEO @ Ohara Pharmaceutical
President and CEO
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-16 | HACARUS | Ohara Pharmaceutical investment in Series B - HACARUS | 1.3 B JPY |
| 2020-07-30 | J-Pharma | Ohara Pharmaceutical investment in Series D - J-Pharma | 1.75 M JPY |
| 2020-04-30 | Helium Health | Ohara Pharmaceutical investment in Series A - Helium Health | 10 M USD |
| 2019-04-01 | PRISM BioLab | Ohara Pharmaceutical investment in Venture Round - PRISM BioLab | 200 M JPY |
| 2018-12-07 | HekaBio | Ohara Pharmaceutical investment in Series A - HekaBio | 552 M JPY |
| 2018-10-05 | HACARUS | Ohara Pharmaceutical investment in Series A - HACARUS | 270 M JPY |
| 2018-02-21 | Jiksak Bioengineering | Ohara Pharmaceutical investment in Venture Round - Jiksak Bioengineering | 170 M JPY |
More informations about "Ohara Pharmaceutical"
OHARA Pharmaceutical Co.,Ltd. | 大原薬品工業株式会社
Ohara Pharmaceutical Co.,Ltd. News Release. June 20, 2024. Additional Investment in Revital Healthcare (EPZ) Limited December 19, 2023. Announcement of Recapitalization of Africa …See details»
Business Unit - 大原薬品工業株式会社
Ohara Pharmaceutical is involved in research and development as well as manufacture and distribution of many orphan drugs, including anti-cancer …See details»
Ohara Pharmaceutical - Crunchbase Investor Profile
Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products. New. …See details»
Pipeline - 大原薬品工業株式会社
Ohara Pharmaceutical:Our mission; Orphan drugs (pharmaceuticals for rare medical conditions) business; Generic drugs business; Corporate profile. Our Message; Corporate governance; …See details»
Revital Healthcare received investments from AAIC and …
Dec 28, 2021 Ohara Pharmaceutical Co., Ltd. is a pharmaceutical company that discovers and develops orphan drugs and generic drugs as its mainstay business. The company particularly focuses on the development, …See details»
Ohara Pharmaceutical - Investments, Portfolio & Company Exits
Nov 22, 2023 Ohara Pharmaceutical has made 11 investments. Their most recent investment was on Nov 22, 2023 , when Africa Healthcare Network raised a new funding round. How …See details»
OHARA PHARMACEUTICAL CO., LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OHARA PHARMACEUTICAL CO., LTD. of KOKA, SHIGA. Get the latest business insights from Dun & …See details»
Ohara Pharmaceutical Co., Ltd. - Drug pipelines, Patents, Clinical ...
About Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific …See details»
Organization | OHARA Pharmaceutical Co., Ltd.
OHARA Pharmaceutical Co., Ltd. Report issue For profit Phase 1 Phase 2 Founded: Tokyo Japan (1964)See details»
Ohara Pharmaceutical Company Profile - Office Locations ... - Craft
Ohara Pharmaceutical is a company that specializes in manufacturing orphan and generic drugs. It provides pharmaceutical products for the treatment of childhood cancers, liver cirrhosis, …See details»
Our Message | 大原薬品工業株式会社 - ohara-ch.co.jp
A message from Ohara Pharmaceutical. ... Ohara entered into a strategic alliance with three trading companies with the aim of achieving a new company mission, “Creation and Symbiosis”. With business units focused on developing …See details»
J-Pharma raises 500 Million JPY from Ohara Pharmaceutical Co., Ltd.
Mar 4, 2021 Ohara Pharmaceutical Co., Ltd., is a pharmaceutical company involved in the development and creative marketing of orphan drugs and generic drugs. The company …See details»
Ohara Pharmaceutical - Products, Competitors, Financials, …
Related Reports Primary Biliary Cholangitis Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical …See details»
Ohara’s Cancer Med Erwinase Reaches Japan Market Over 6 Years …
Jun 15, 2023 Ohara Pharmaceutical finally rolled out its cancer drug Erwinase (crisantaspase) in Japan on June 14, six and a half years after its approval in 2016, now that the company has a …See details»
Ohara Obtains Exclusive Rights to Biliary Tract Cancer Drug
Feb 23, 2015 Ohara Pharmaceutical said on April 25 that it has entered into a license and joint development agreement with drug discovery biotech J-Pharma for its biliary tract cancer …See details»
Corporate history - 大原薬品工業株式会社
Obtained all stocks for Sankyo Yell Pharmaceutical Co., Ltd. From Sankyo Co., Ltd., jointly with the group companies: October 2007: Tokyo Head Office was established at St. Luke’s Tower: …See details»
Generic Player Ohara Looks to Morph into Innovative Drug Maker, …
Feb 13, 2019 Japanese generic maker Ohara Pharmaceutical will shift the core of its business to new drugs, narrowing its focus to life-threatening diseases such as childhood cancers, which …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Pharmaceutical organizations often struggle with time-consuming processes that demand excessive involvement across multiple levels of the company, including financial …See details»
Ohara Pharmaceutical Co., Ltd. - 大原薬品工業株式会社
Ohara Pharmaceutical Co., Ltd. (Headquarters: Koga, Shiga Prefecture, President and Representative Director: Seiji Ohara) announces that its novel OP - 724 (PRI - 724) program …See details»
Ohara Join Hands with Nigerian Pharma, Eying Future
May 17, 2019 Ohara Pharmaceutical said on May 16 that it has entered into a strategic capital and business alliance agreement with Nigerian major pharma company Fidson Healthcare. …See details»